Nasopharyngeal carcinoma: can antiviral interventions be contemplated to prevent this cancer?
D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D000998:Antiviral Agents / Q000627:therapeutic use; D002338:Carotenoids / Q000627:therapeutic use; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007372:Interferons / Q000627:therapeutic use; D009303:Nasopharyngeal Neoplasms / Q000517:prevention & control*; D009305:Nasopharynx / Q000473:pathology; D011230:Precancerous Conditions / Q000473:pathology; D012306:Risk; D014412:Tumor Virus Infections / Q000517:prevention & control*; D019207:beta Carotene
D000914:Antibodies, Viral; D000998:Antiviral Agents; D007070:Immunoglobulin A; D019207:beta Carotene; D002338:Carotenoids; D007372:Interferons